Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.01448-22Source: DataRank Database

QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies is a research paper published in Antimicrobial Agents and Chemotherapy (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.00)OA: hybridTopics (27)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Kendra K. Radtke ORCID,Anneke C. Hesseling ORCID,Jana Winckler ORCID,H. Simon Schaaf ORCID,Heather R. Draper

Live enrichment

PubMed:37358463 PMC:PMC10353402 OpenAlex:https://openalex.org/W4382011279

Bill and Melinda Gates Foundation

Grant: OPP1191117

HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development

Grant: R01HD069169

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R01HD083047

FWCI

2.00

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1128/aac.01448-22

publisherhttps://doi.org/10.1128/aac.01448-22

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.01448-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37358463

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10353402

Fields of Study

Cardiac electrophysiology and arrhythmiasTuberculosis Research and EpidemiologyAntimicrobial Resistance in Staphylococcus

MeSH Terms

AdolescentAntitubercular AgentsChildChild, PreschoolClofazimineElectrocardiographyHumansRifampinSouth AfricaTuberculosis, Multidrug-ResistantLevofloxacin

Keywords

MedicineQT intervalMoxifloxacinBedaquilineLevofloxacinRegimenPharmacologyInternal medicineTuberculosisAntibioticsPediatricsQt ProlongationDrug-drug Interaction

Sustainable Development Goals

SDG 0: Good health and well-being